Latest Breaking News On - Breast cancer congress - Page 1 : comparemela.com

Novel CDK4 Inhibitor Shows Activity and Safety in HR+/HER2– Metastatic Breast Cancer

Novel CDK4 Inhibitor Shows Activity and Safety in HR+/HER2– Metastatic Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Texas
United-states
United-kingdom
Houston
Radiopharm-theranostics
Institut-gustave-roussy
Timothya-yap
Eli-lilly
Pfizer
Clinical-development
Cancer-research-united-kingdom
Zenith

Addition of Denosumab to Neoadjuvant Chemo Does Not Lead to Significant iDFS Differences in Early Breast Cancer

Addition of Denosumab to Neoadjuvant Chemo Does Not Lead to Significant iDFS Differences in Early Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Germany
German
Menarini-stemline
Pierre-fabre
Forschungs-gmb
Pfizer
Amgen
Novartis
Astrazeneca
German-breast-group
Molecular-health
Breast-cancer-congress

Ribociclib Plus NSAI Maintains Manageable Safety Profile in HR+/HER2– Early Breast Cancer

Ribociclib Plus NSAI Maintains Manageable Safety Profile in HR+/HER2– Early Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United-states
Porto-alegre
Rio-grande-do-sul
Brazil
America
Astellas-pharma
Bristol-myers-sqiubb
Roche-genentech
Carlos-barrios
Daiichi-sankyo
Abraxis-biosciences
Novartis